← Open Payments lookup

SAHAR AZIM: Open Payments

NPI 1811428477 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,645 in 89 payments from 17 companies in 2025. Trend: 2023 $511 · 2024 $603 · 2025 $1,645

Food & beverage: $1,645
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.20$310
Janssen Pharmaceuticals, Inc8$280
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$203
E.R. Squibb & Sons, L.L.C.5$123
Neurocrine BioSciences, Inc.5$111
Axsome Therapeutics, Inc.4$87
Teva Pharmaceuticals USA, Inc.3$85
Alkermes, Inc.3$82
ABBVIE INC.4$74
Almatica Pharma LLC4$59

Products named: REXULTI, SPRAVATO, CAPLYTA, COBENFY, INGREZZA, ABILIFY ASIMTUFII, Auvelity, ARISTADA.

Industry payments across NV — which companies pay providers there.